A small cohort of pregnant women with type 1 diabetes improved time in range with use of a closed-loop insulin delivery system with a zone model predictive control algorithm, according to findings ...

Objective—This study evaluated closed-loop insulin delivery with a model predictive control (MPC) algorithm during early (12–16 weeks) and late gestation (28–32 weeks) in pregnant women with type 1 ...

Meeting the primary endpoint, the mean percentage of time that the maternal glucose level was in the target range was 68.2% with the hybrid closed-loop system and 55.6% with standard insulin therapy ...

Compared with standard care, a closed-loop insulin delivery system increased the time spent within the pregnancy-specific glucose target range between 16 and 34 weeks 6 days ’ gestation among pregnant ...

Results from the AiDAPT trial show hybrid closed-loop therapy significantly improves maternal glycemic control during pregnancy complicated by T1D. Hybrid closed-loop insulin therapy significantly ...

Please provide your email address to receive an email when new articles are posted on . Pregnant women with type 1 diabetes had a lower time below range with the MiniMed 780 system vs. standard of ...

FRIDAY, Oct. 6, 2023 (HealthDay News) -- For pregnant women with type 1 diabetes, hybrid closed-loop insulin therapy significantly improves maternal glycemic control, according to a study published ...

Camilla Levister, MS, ANP-C, CDCES, a nurse practitioner at the Icahn School of Medicine at Mount Sinai Hospital in New York, discusses how closed-loop artificial pancreas systems can help reduce the ...

A new study endorses closed-loop use in type 1 diabetes pregnancy and highlights how the technology can facilitate positive pregnancy experiences. The study is published in the peer-reviewed journal ...